Loomis Sayles & CO L P Meridian Bioscience Inc Transaction History

Loomis Sayles & CO L P

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$10.88 - $17.6 $11,326 - $18,321	-1,041 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$15.51 - $17.61 $16,145 - $18,332	1,041 New	1,041 $18,000
Q2 2018 Aug 14, 2018	SELL	$13.8 - $16.8 $19,582 - $23,839	-1,419 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$13.8 - $16.2 $13,579 - $15,940	984 Added 226.21%	1,419 $20,000
Q4 2017 Feb 14, 2018	SELL	$13.55 - $15.8 $5,501 - $6,414	-406 Reduced 48.28%	435 $6,000
Q3 2017 Nov 14, 2017	BUY	$13.45 - $14.35 $5,460 - $5,826	406 Added 93.33%	841 $12,000
Q2 2017 Aug 14, 2017	BUY	N/A	435	435 $7,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.